These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31313283)

  • 1. CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
    Demarest ST; Olson HE; Moss A; Pestana-Knight E; Zhang X; Parikh S; Swanson LC; Riley KD; Bazin GA; Angione K; Niestroj LM; Lal D; Juarez-Colunga E; Benke TA
    Epilepsia; 2019 Aug; 60(8):1733-1742. PubMed ID: 31313283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.
    Mulcahey PJ; Tang S; Takano H; White A; Davila Portillo DR; Kane OM; Marsh ED; Zhou Z; Coulter DA
    Exp Neurol; 2020 Oct; 332():113388. PubMed ID: 32585155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKL5 deficiency disorder and other infantile-onset genetic epilepsies.
    Daniels C; Greene C; Smith L; Pestana-Knight E; Demarest S; Zhang B; Benke TA; Poduri A; Olson HE;
    Dev Med Child Neurol; 2024 Apr; 66(4):456-468. PubMed ID: 37771170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First report of Tunisian patients with CDKL5-related encephalopathy.
    Charfi Triki C; Zouari Mallouli S; Ben Jdila M; Ben Said M; Kamoun Feki F; Weckhuysen S; Masmoudi S; Fakhfakh F
    Epilepsia Open; 2024 Jun; 9(3):906-917. PubMed ID: 37701975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKL5-associated developmental and epileptic encephalopathy: A long-term, longitudinal electroclinical study of 22 cases.
    Darra F; Monchelato M; Loos M; Juanes M; Bernardina BD; Valenzuela GR; Gallo A; Caraballo R
    Epilepsy Res; 2023 Feb; 190():107098. PubMed ID: 36739728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKL5 Deficiency Disorder Without Epilepsy.
    Aznar-Laín G; Fernández-Mayoralas DM; Caicoya AG; Rocamora R; Pérez-Jurado LA
    Pediatr Neurol; 2023 Jul; 144():84-89. PubMed ID: 37201242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
    MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
    Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.
    Brock D; Fidell A; Thomas J; Juarez-Colunga E; Benke TA; Demarest S
    J Child Neurol; 2021 Oct; 36(11):974-980. PubMed ID: 34547934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.
    Terzic B; Cui Y; Edmondson AC; Tang S; Sarmiento N; Zaitseva D; Marsh ED; Coulter DA; Zhou Z
    Neurobiol Dis; 2021 Jan; 148():105176. PubMed ID: 33197557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations and epilepsy treatment in Japanese patients with pathogenic CDKL5 variants.
    Kobayashi Y; Tohyama J; Takahashi Y; Goto T; Haginoya K; Inoue T; Kubota M; Fujita H; Honda R; Ito M; Kishimoto K; Nakamura K; Sakai Y; Takanashi JI; Tanaka M; Tanda K; Tominaga K; Yoshioka S; Kato M; Nakashima M; Saitsu H; Matsumoto N
    Brain Dev; 2021 Apr; 43(4):505-514. PubMed ID: 33436160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.
    Hong W; Haviland I; Pestana-Knight E; Weisenberg JL; Demarest S; Marsh ED; Olson HE
    CNS Drugs; 2022 Jun; 36(6):591-604. PubMed ID: 35633486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.
    Olson HE; Demarest ST; Pestana-Knight EM; Swanson LC; Iqbal S; Lal D; Leonard H; Cross JH; Devinsky O; Benke TA
    Pediatr Neurol; 2019 Aug; 97():18-25. PubMed ID: 30928302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure.
    Olson HE; Costantini JG; Swanson LC; Kaufmann WE; Benke TA; Fulton AB; Hansen R; Poduri A; Heidary G
    Dev Med Child Neurol; 2021 Nov; 63(11):1308-1315. PubMed ID: 34028805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients.
    Archer HL; Evans J; Edwards S; Colley J; Newbury-Ecob R; O'Callaghan F; Huyton M; O'Regan M; Tolmie J; Sampson J; Clarke A; Osborne J
    J Med Genet; 2006 Sep; 43(9):729-34. PubMed ID: 16611748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
    Amin S; Møller RS; Aledo-Serrano A; Arzimanoglou A; Bager P; Jóźwiak S; Kluger GJ; López-Cabeza S; Nabbout R; Partridge CA; Schubert-Bast S; Specchio N; Kälviäinen R
    Epilepsia Open; 2024 Jun; 9(3):832-849. PubMed ID: 38450883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evolution and epilepsy outcome in three patients with CDKL5-related developmental encephalopathy.
    Bernardo P; Ferretti A; Terrone G; Santoro C; Bravaccio C; Striano S; Coppola A; Striano P
    Epileptic Disord; 2019 Jun; 21(3):271-277. PubMed ID: 31225800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures.
    Wang HT; Zhu ZA; Li YY; Lou SS; Yang G; Feng X; Xu W; Huang ZL; Cheng X; Xiong ZQ
    Epilepsia; 2021 Feb; 62(2):517-528. PubMed ID: 33400301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).
    Saldaris J; Leonard H; Jacoby P; Marsh ED; Benke TA; Demarest S; Downs J
    J Child Neurol; 2022 May; 37(6):541-547. PubMed ID: 35422141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestation of CDKL5 deficiency disorder and identified mutations in a cohort of Slovak patients.
    Kluckova D; Kolnikova M; Medova V; Bognar C; Foltan T; Svecova L; Gnip A; Kadasi L; Soltysova A; Ficek A
    Epilepsy Res; 2021 Oct; 176():106699. PubMed ID: 34229227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder.
    Yennawar M; White RS; Jensen FE
    J Neurosci; 2019 Jun; 39(24):4814-4828. PubMed ID: 30952813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.